Dose escalation/expansion trial with BYON4228 alone and in combination in metastatic solid tumors

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517952-37-00

Acronym

BYON4228.002

Enrollment

Registered

2025-04-30

Start date

2025-05-22

Completion date

Unknown

Last updated

2025-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally advanced or metastatic cancer (Solid tumors)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026